India to Italy: Cabazitaxel Export Trade Route

The India to Italy Cabazitaxel corridor is one of India's established pharmaceutical export routes, with 9 shipments documented worth a combined $1.4M USD. The route is dominated by INTAS PHARMACEUTICALS LIMITED , which alone accounts for roughly 43% of all export value, reflecting the consolidated nature of India's cabazitaxel manufacturing sector.

Across 4 active suppliers, the average shipment value stands at $151.8K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 84% of all shipments, consistent with cabazitaxel's non-urgent bulk-order profile.

Shipment activity peaks during October–December, with an average transit time of 31 days port-to-port. The route has recorded an annual growth rate of 33.7%, placing it at rank #3 among India's top cabazitaxel export destinations globally.

On the import side, key buyers of Indian cabazitaxel in Italy include ACCORD HEALTHCARE ITALIA SRL. , XX RXXDYSXXRL, DR REDDYS S R L and 2 others. ACCORD HEALTHCARE ITALIA SRL. is the single largest importer with 2 shipments valued at $451.6K USD.

India's cabazitaxel exports to Italy are driven primarily by a handful of large-scale manufacturers. INTAS PHARMACEUTICALS LIMITED with 3 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 4 active exporters signals a competitive but concentrated market — buyers in Italy benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — INTAS PHARMACEUTICALS LIMITED , DR REDDY S LABORATORIES LIMITED, DR REDDYS LABORATORIES LIMITED — together account for 98% of total trade value on this route. The average shipment value of $151.8K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

Beyond the primary product category, shipments on this route include closely related formulations such as pharma drug&med:cabazitaxel 20mg/ml 3ml( and pharma drug&med: cabazitaxel 20mg/ml 3ml(accord-italy each ml contains 20 mg cabazitaxel each 3 ml vial contains 60 mg c, suggesting that buyers in Italy tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, ACCORD HEALTHCARE ITALIA SRL. is the largest importer with 2 shipments worth $451.6K USD — representing 33% of all cabazitaxel imports from India on this route.